My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

20.85 +0.71 (+3.53%)
Streaming Delayed Price Updated: 1:48 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eton Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Eton Pharmaceuticals Stock Tumbles After FDA Rejects its Dehydrated Alcohol Injection Application For Methanol Poisoning
Eton Pharmaceuticals Inc has received a Complete Response Letter from the FDA related to a marketing application for its dehydrated alcohol injection to treat methanol poisoning. 
Via Talk Markets
Eton Pharmaceuticals Stock Tumbles After FDA Rejects its Dehydrated Alcohol Injection Application For Methanol Poisoning
Eton Pharmaceuticals Inc (NASDAQ: ETON) has received a Complete Response Letter (CRL) from the FDA related to a marketing application for its dehydrated alcohol... 
Via Benzinga
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. 
Via Talk Markets
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.... 
Via Benzinga
Eton Pharmaceuticals: Q1 Earnings Insights
Shares of Eton Pharmaceuticals (NASDAQ:ETON) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 138.00... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
Via Benzinga
42 Biggest Movers From Yesterday
Gainers Esports Technologies, Inc. (NASDAQ: EBET) shares jumped 507% to settle at $36.42 on Thursday. agilon health, inc. (NYSE: AGL) gained 34.8% to close at $31.00 after the... 
Via Benzinga
Mid-Afternoon Market Update: Gold Jumps 1.8%; Dell Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.86% to 34,022.21 while the NASDAQ rose 1.25% to 14,030.90. The S&P also rose, gaining 1.06% to 4,168.23. The U.S. has... 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.